Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) Bundle
Rooted in Nyingchi since its founding in 1995 by Yangjin Lamu and Lei Jufang, Tibet Cheezheng Tibetan Medicine Co., Ltd. has grown into a powerhouse in Tibetan ethnomedicine with more than 3,000 employees across 22 subsidiaries, including GMP-certified factories and GSP-compliant marketing firms, producing signature remedies like Qingpeng ointment and Xiaotong paste that are clinically recognized for conditions such as acute gouty arthritis; guided by a mission to blend traditional Tibetan herbal wisdom with modern pharmaceutical rigor, the company pursues innovation, stringent safety and efficacy standards, consumer education, and global expansion while upholding corporate social responsibility and sustainability in Tibetan communities-part of a trajectory that in 2016 placed founder Lei Jufang among China's wealthiest in medicine at US$1.85 billion and ranked her No. 146 on Forbes' list of China's 400 richest, with industry recognition including the first prize in the First Chinese Ethnomedicine Science and Technology Progress Award in 2014
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) - Intro
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) is a leading integrated enterprise in China's Tibetan medicine industry, focused on the research, development, production, and marketing of traditional Tibetan medicinal products. Founded in 1995 in Nyingchi, Tibet by Yangjin Lamu and Lei Jufang, the company has scaled from a regional producer to a national-listed firm with extensive manufacturing and distribution capabilities.- Founded: 1995 (Nyingchi, Tibet)
- Founders: Yangjin Lamu and Lei Jufang
- Listing: Shenzhen Stock Exchange (002287.SZ)
- Employees: >3,000 across group (latest reported)
- Subsidiaries: 22, including GMP-certified pharmaceutical factories and GSP-compliant marketing firms
- Therapeutic areas: musculoskeletal, nervous, digestive, cardiovascular, respiratory, urinary, gynecological, dermatological, pediatric
- Flagship products: Qingpeng ointment, Xiaotong paste (widely used for joint pain and soft-tissue conditions)
- Clinical recognition: evidence of efficacy in conditions such as acute gouty arthritis for topical Tibetan formulations
- 2014: Recipient - First Prize, First Chinese Ethnomedicine Science and Technology Progress Award
- 2016: Founder Lei Jufang listed by Forbes - net worth US$1.85 billion; ranked No.146 among China's 400 Richest
- Quality systems: Multiple GMP-certified production sites; GSP-compliant marketing and distribution network
| Metric | Value / Note |
|---|---|
| Year Founded | 1995 |
| Employees | >3,000 |
| Number of Subsidiaries | 22 |
| GMP/GSP Compliance | GMP-certified factories; GSP-compliant marketing firms |
| Notable Products | Qingpeng ointment, Xiaotong paste |
| Major Award | 2014 - First Prize, Chinese Ethnomedicine Science & Technology Progress |
| Founder Wealth (2016) | Lei Jufang - US$1.85 billion (Forbes China 400 rank #146) |
- Mission: To inherit and modernize Tibetan medicine through standardized R&D and manufacturing while improving patient outcomes across broad therapeutic areas.
- Vision: To be the authoritative bridge between traditional Tibetan medical knowledge and modern pharmaceutical standards, scaling safe, effective ethnomedicines domestically and internationally.
- Core values: Cultural stewardship of Tibetan medicine, scientific rigor, quality compliance (GMP/GSP), accessibility of treatments, sustainable growth and social responsibility.
- R&D focus: Standardization of Tibetan materia medica, clinical validation of topical and systemic formulations, and product diversification across multiple indications.
- Manufacturing posture: Investment in GMP production lines and process controls to meet national pharmaceutical standards.
- Market reach: Nationwide distribution via GSP-compliant subsidiaries and retail channels; brand recognition anchored by flagship topical analgesics.
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) - Overview
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) centers its corporate identity on integrating centuries-old Tibetan medicinal knowledge with contemporary pharmaceutical science to deliver safe, effective herbal therapies. The company's strategic priorities align product integrity, regulatory compliance, and scalable innovation to expand both domestic presence and international reach.- Mission: Preserve and modernize Tibetan medicine by developing clinically validated natural products derived from Tibetan herbs and traditional formulations.
- Quality & Safety: Commit to Good Manufacturing Practice (GMP) standards, pharmacovigilance, and third‑party testing to ensure consumer trust and product consistency.
- Innovation: Invest in R&D to translate traditional recipes into standardized, evidence‑based formulations addressing musculoskeletal, respiratory, and chronic-care markets.
- Education & Outreach: Provide patient and practitioner education programs to increase awareness and correct usage of Tibetan medicinal therapies.
- Global Expansion: Pursue strategic partnerships, licensing, and export initiatives to grow international sales while protecting traditional knowledge.
- Corporate Social Responsibility: Support community cultivation projects, sustainable herb sourcing, and local healthcare education to strengthen supply chains and social license to operate.
| Metric | Latest reported value (indicative) | Notes |
|---|---|---|
| Annual Revenue (RMB) | ~1.1 billion | Reported in recent fiscal disclosures; revenue mix: OTC herbal products, prescription Tibetan formulations, and hospital sales. |
| Net Profit (RMB) | ~120 million | Net margin reflects manufacturing scale, marketing, and R&D allocation. |
| R&D Investment | ~3-5% of revenue | Funding clinical trials, formulation standardization, and quality-control technologies. |
| Employees | ~2,500-3,000 | Includes manufacturing, R&D, sales, and clinic personnel across Tibet, Sichuan, and other provinces. |
| Retail / Medical Outlets Served | ~3,000-4,000 | Combination of company stores, distributor networks, and hospital channels. |
| Export / Overseas Revenue Share | ~8-12% | Growing via targeted markets in Asia, Europe, and specialty herbal distributors. |
- Strategic KPIs: scale production without compromising herb traceability; raise R&D yield measured by number of validated formulations per year; increase direct-to-consumer digital sales share.
- Risk management priorities: sustainable herb sourcing, regulatory compliance across export markets, and preserving efficacy while standardizing traditional multi‑component remedies.
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) - Mission Statement
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) positions its mission around preserving and modernizing Tibetan medicinal heritage while delivering effective, safe, and accessible natural health solutions for physical and mental well-being. The company aligns strategic growth with scientific validation, quality control, and expanded therapeutic coverage to meet contemporary health needs.- Deliver clinically effective external analgesic and internal therapeutic products derived from Tibetan medical traditions, validated by modern research and quality systems.
- Scale production and distribution to make Tibetan medicine widely available across mainland China and selected international markets.
- Invest in R&D and technology to modernize formulations, ensure safety, and improve patient outcomes.
- Maintain ethical sourcing of medicinal materials and support sustainable, traceable supply chains from Tibetan regions.
- Lead the external analgesic products industry and become the largest Tibetan medicine enterprise in mainland China by market share and recognized quality benchmarks.
- Expand product range to cover musculoskeletal, rheumatologic, pain management, dermatologic, and supportive mental-wellness categories.
- Integrate modern technology (quality control, formulation science, digital health) while preserving the essence of Tibetan medicinal practice.
- Build international recognition via regulatory approvals, partnerships, and evidence-based publications.
| Metric | Value / Target | Notes |
|---|---|---|
| Ticker | 002287.SZ | Listed on Shenzhen Stock Exchange |
| Primary focus | External analgesics, Tibetan proprietary medicines | Core competitive advantage |
| Geographic reach | All 31 mainland provinces; select export markets | Extensive domestic distribution network |
| R&D investment (target) | ~5-7% of revenue (strategic target) | Support for clinical trials and formulation modernization |
| Product SKUs | Dozens (external analgesics + internal formulations) | Expanding into adjacent therapeutic areas |
| Quality certifications | GMP, national drug approvals | Foundation for scaling and export |
- Accelerate clinical and pharmacological research to substantiate efficacy and safety claims, supporting regulatory approvals domestically and abroad.
- Scale manufacturing capacity with standardized GMP processes and digitized quality management to ensure batch consistency.
- Diversify product pipelines into pain management, joint health, dermatology, and behavioral-health support, pairing traditional formulas with modern delivery systems.
- Strengthen supply-chain traceability for Tibetan medicinal herbs, invest in sustainable cultivation, and support community partnerships in source regions.
- Leverage digital channels, physician education, and real-world evidence to increase clinician and consumer trust.
| Timeframe | Target | Indicator |
|---|---|---|
| Short-term (1-2 years) | Increase market share in external analgesics | Growth in retail penetration and hospital formularies |
| Medium-term (3-5 years) | Expand therapeutic portfolio by 30-50% of current SKUs | Launch of new formulations and indications |
| Long-term (5-10 years) | Establish recognized global presence | Regulatory approvals and exports to multiple regions |
- Integration of modern analytical methods and quality-by-design in production processes to ensure consistency with traditional formulations.
- Partnerships with research institutions to publish clinical and pharmacodynamic studies validating key products.
- Investment in talent and manufacturing scale to meet higher-volume domestic demand and prepare for export certification.
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) - Vision Statement
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) aspires to be the global leader in integrating traditional Tibetan medicine with modern healthcare technology, delivering safe, effective, and culturally grounded remedies while driving sustainable development in Tibetan regions and beyond.- Preserve and modernize Tibetan medical heritage through scientific validation and technological integration.
- Innovate continuously to create clinically effective formulations that meet contemporary health challenges (chronic pain, musculoskeletal disorders, metabolic health).
- Maintain uncompromising quality and regulatory compliance to build long-term consumer trust.
- Invest in community development, education, and ecological stewardship in Tibetan areas to ensure sustainable raw-material supply chains and social license to operate.
- Forge strategic domestic and international partnerships to expand research, manufacturing capacity, and market access.
| Metric | Value (most recent fiscal year) | Notes |
|---|---|---|
| Revenue | ≈ RMB 1.2 billion | Core sales from traditional formulations, topical treatments, and OTC channels |
| Net profit | ≈ RMB 120 million | Profitability supported by branded products and gross margin management |
| R&D investment | ≈ RMB 45-55 million (≈3.5-4.5% of revenue) | Focus on formulation R&D, clinical trials, and quality-control technology |
| CSR & community investment | RMB 5-12 million | Programs in education, cultivation of medicinal plants, and local health services |
| Export / international sales | ~5-12% of revenue | Growing but still a minority; strategic partnerships aim to increase this share |
- Quality assurance: multi-tier QC labs, GMP-compliant manufacturing, and post-market surveillance to keep adverse-event rates low and consumer confidence high.
- Innovation pipeline: combining ethnopharmacology with modern pharmacology to create next-generation topical and oral formulations aimed at pain relief and joint health.
- Sustainability programs: standardized cultivation plots for key Tibetan botanicals to reduce overharvesting and improve traceability.
- Community uplift: scholarships for Tibetan medical students, training programs for local collectors, and clinic sponsorships in rural counties.
- Strategic alliances: collaboration with universities, research institutes, and distribution partners to scale clinical validation and market reach.
| Outcome | Target / Result | Timeframe |
|---|---|---|
| Increase R&D intensity | Raise R&D spend to 5% of revenue | 3 years |
| Expand international presence | Double export share to ~20% of revenue | 5 years |
| Sustainable sourcing | All key herbs sourced from certified cultivation zones | Ongoing, phased over 4 years |
| Community impact | Fund 100 scholarships & 10 rural clinics | 3 years |
- Accelerate clinical research and publish safety/efficacy data to support overseas registration.
- Scale GMP-capable production lines and invest in automation to improve margin and capacity.
- Deepen vertical integration for raw materials to secure quality and reduce input volatility.
- Pursue joint ventures and licensing to enter complementary therapeutic categories and markets.
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.